416 related articles for article (PubMed ID: 28140447)
21. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
22. Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.
Suk Lee Y; Davila E; Zhang T; Milmoe HP; Vogel SN; Bromberg JS; Scalea JR
Innate Immun; 2019 Jan; 25(1):46-59. PubMed ID: 30782043
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
24. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
[TBL] [Abstract][Full Text] [Related]
25. Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells.
Xie Z; Ago Y; Okada N; Tachibana M
J Pharmacol Sci; 2018 Aug; 137(4):359-365. PubMed ID: 30177294
[TBL] [Abstract][Full Text] [Related]
26. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.
Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H
Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870
[TBL] [Abstract][Full Text] [Related]
27. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
[TBL] [Abstract][Full Text] [Related]
28. Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells.
Zhou F; Zhang GX; Rostami A
Immunol Res; 2016 Feb; 64(1):73-81. PubMed ID: 26111522
[TBL] [Abstract][Full Text] [Related]
29. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
30. Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
Melero-Jerez C; Ortega MC; Moliné-Velázquez V; Clemente D
Biochim Biophys Acta; 2016 Mar; 1862(3):368-80. PubMed ID: 26527182
[TBL] [Abstract][Full Text] [Related]
31. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
Melero-Jerez C; Suardíaz M; Lebrón-Galán R; Marín-Bañasco C; Oliver-Martos B; Machín-Díaz I; Fernández Ó; de Castro F; Clemente D
Neurobiol Dis; 2019 Jul; 127():13-31. PubMed ID: 30798007
[TBL] [Abstract][Full Text] [Related]
32. PD-1 expression is upregulated on adapted T cells in experimental autoimmune encephalomyelitis but is not required to maintain a hyporesponsive state.
Mair I; Besusso D; Saul L; Patel SD; Ravindran R; McPherson RC; Leech MD; O'Connor RA; Anderton SM; Mellanby RJ
Eur J Immunol; 2019 Jan; 49(1):112-120. PubMed ID: 30485411
[TBL] [Abstract][Full Text] [Related]
33. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
Jiang Q; Duan J; Van Kaer L; Yang G
Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
[TBL] [Abstract][Full Text] [Related]
34. Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice.
Ostrand-Rosenberg S; Sinha P; Figley C; Long R; Park D; Carter D; Clements VK
J Leukoc Biol; 2017 May; 101(5):1091-1101. PubMed ID: 28007981
[TBL] [Abstract][Full Text] [Related]
35. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
36. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
37. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
Critchfield JM; Racke MK; Zúñiga-Pflücker JC; Cannella B; Raine CS; Goverman J; Lenardo MJ
Science; 1994 Feb; 263(5150):1139-43. PubMed ID: 7509084
[TBL] [Abstract][Full Text] [Related]
38. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.
Jiang H; Braunstein NS; Yu B; Winchester R; Chess L
Proc Natl Acad Sci U S A; 2001 May; 98(11):6301-6. PubMed ID: 11353822
[TBL] [Abstract][Full Text] [Related]
39. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
[TBL] [Abstract][Full Text] [Related]
40. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
